Top Authors

• Most frequent coverage on MNKD

• 
  Ahithophel Weissberger (14 followers)

  • Mannkind: Overlooked Biotech With Excellent Prospects (Part VI) (Sun, Jun 22)
  • Mannkind: Overlooked Biotech With Excellent Prospects (Part V) (Thu, Jun 19)
  • Mannkind: Overlooked Biotech With Excellent Prospects (Part IV) (Tue, Jun 17)

  More by Ahithophel Weissberger on MNKD »
• 
  R.J Steffens (18 followers)

  • Oral-lyn vs. Afresa: How Generex Will Beat Mannkind (Thu, Nov 19)
  • ADA's 68th Scientific Sessions: A New Look at Insulin Therapy (Tue, Jun 10)
  • Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada (Mon, May 5)

  More by R.J Steffens on MNKD »
• 
  Mike Huckman (225 followers)

  • Fixing Pfizer (Sun, May 4)
  • MannKind: No Partnership Likely for Inhalable Insulin (Fri, Apr 11)
  • Inhaled Insulin: One Giant Leap for MannKind (Tue, Mar 11)

  More by Mike Huckman on MNKD »

• Most followed authors on MNKD

• 
  Mike Havrilla (1937 followers)

  • Diabetes Care: Global Investing Opportunities (Sun, Nov 22)
  • BioMed News: Rockwell Medical, EXACT Sciences, MannKind (Fri, Oct 30)
  • Emisphere: Improving Drug Delivery (Fri, Jun 5)

  More by Mike Havrilla on MNKD »
• 
  Marco Hickey (1316 followers)

  • 15 Possible Healthcare Breakout Stocks (Sun, Jun 21)

  More by Marco Hickey on MNKD »
• 
  Andrew Wilkinson (1163 followers)

  • Monday Options Update: AA, UUP, MNKD & LVLT (Mon, Dec 21)

  More by Andrew Wilkinson on MNKD »

• Newest authors on MNKD

• 
  M. E. Garza (521 followers)

  • BioMimetic Leads Tuesday's Healthcare Winners (Wed, Oct 7)
  • Bio Medical Stock Sector is Where the Action Is (Tue, Jun 9)

  More by M. E. Garza on MNKD »
• 
  The Burrill Report (205 followers)

  • Biotech Discounts Galore (Sun, Aug 9)

  More by The Burrill Report on MNKD »
• 
  VFC's Stock House (1156 followers)

  • Liking the Risk/Reward in Generex (Mon, Oct 12)
  • Why I'm Taking a Foothold in Generex Now (Mon, Oct 12)

  More by VFC's Stock House on MNKD »

• Most commented on MNKD

• 
  Ahithophel Weissberger (14 followers)

  • Mannkind: Overlooked Biotech With Excellent Prospects (Part VI) (Sun, Jun 22)
  • Mannkind: Overlooked Biotech With Excellent Prospects (Part V) (Thu, Jun 19)
  • Mannkind: Overlooked Biotech With Excellent Prospects (Part IV) (Tue, Jun 17)

  More by Ahithophel Weissberger on MNKD »
• 
  R.J Steffens (18 followers)

  • Oral-lyn vs. Afresa: How Generex Will Beat Mannkind (Thu, Nov 19)
  • ADA's 68th Scientific Sessions: A New Look at Insulin Therapy (Tue, Jun 10)
  • Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada (Mon, May 5)

  More by R.J Steffens on MNKD »
• 
  Mike Huckman (225 followers)

  • Fixing Pfizer (Sun, May 4)
  • MannKind: No Partnership Likely for Inhalable Insulin (Fri, Apr 11)
  • Inhaled Insulin: One Giant Leap for MannKind (Tue, Mar 11)

  More by Mike Huckman on MNKD »